• Philip Hockberger

Horizon Therapeutics Announces Plans for Chicago

Sept 28, 2020 - Horizon Therapeutics announced today that it has agreed to purchase the three-building campus in Deerfield, IL, that formerly belonged to Takeda Pharmaceuticals. The transaction is expected to close in the first quarter with additional terms of the purchase not disclosed. Horizon is expected to occupy the campus in the second half of this year.

The Deerfield campus totals 70 acres and consists of more than 650,000 square feet of building space. Horizon is being represented in the transaction by CBRE.

For more information, click here.


Recent Posts

See All

Chicago Biomedical Innovation Alliance

© 2019 by Philip Hockberger

Created using

633 Clark St, Crown North Tower, room 2-543, Evanston, IL 60208


Tel: 847-467-1509